Funding for this research was provided by:
UNDP, UNFPA, UNICEF, WHO, World Bank Special Programme of Research, Development and Research Training in Human Reproduction
Argentinian Fund for Horizontal Cooperation of the Argentinean Ministry of Foreign Affairs, South-South and Triangular Cooperation
Research Council of Norway and the Centre for Intervention Science in Maternal and Child Health (Project number 223269)
Bill and Melinda Gates Foundation (Global Health Grant Number OPP1017337)
Received: 8 March 2017
Accepted: 2 October 2017
First Online: 26 October 2017
Ethics approval and consent to participate
: Ethical approval for the trial was obtained from the Human Research Ethics Committee of the University of the Witwatersrand, Johannesburg (certificate number M10977), the Faculty of Health Sciences Human Research Ethics Committee, Cape Town (HREC 457/2010), Health Research Ethics Committee 1 (certificate number M12/01/002), the Medical Research Council of Zimbabwe (certificate number MRCZ/A/1599), and the Argentinean National Ethical Committee, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), (Protocol Number: 725). In addition, the trial protocol was approved by the Research Project Review Panel of the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development, and Research Training in Human Reproduction at the Department of Reproductive Health and Research of WHO and the WHO Research Ethics Review Committee, Geneva, Switzerland (certificate number A65750). All participants enrolled in the trial provided written informed consent.
: Not applicable
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.